Clinical Trial Update: Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease [NA]

View source ↗

Summary

A completed clinical trial update evaluating new specifications (38mm) of Firehawk in treating coronary heart disease; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Firehawk

Snippet

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. | Conditions: Coronary Heart Disease | NA | Status: COMPLETED | Results posted: 2020-02-20